Abstract
The hamster polyomavirus (HaPV) was first described in 1967 as a virus associated with skin epithelioma of the Syrian hamster. The tumors appear spontaneously in a hamster colony bred in Berlin-Buch (HaB). Virus particles isolated from skin epitheliomas cause lymphoma and leukemia when injected into newborn hamsters from a distinct colony bred in Potsdam, Germany (HaP). The viral genome has been totally sequenced and the overall genetic organization establishes HaPV as a member of the polyomaviruses. HaPV is a second example of an middle T (MT) antigen encoding polyomavirus and nucleotide sequence homologies designates the mouse polyomavirus (Py) as the closest relative.
Lymphomas induced by HaPV in HaP hamsters do not contain virus particles but instead accumulate different amounts of nonrandomly deleted free and/or integrated viral genomes. Transgenic mice produced by microinjection of HaPV DNA into the pronucleus of fertilized eggs of Gat: NMRI mice developed both, epitheliomas and lymphomas. Both tumor types contain extrachromosomal DNA.
HaPV DNA was found to replicate in hamster lymphoid and fibroblast cell lines. Fully reproductive cycles could be detected only in GD36 lymphoblastic leukemia cells.
HaPV carries the full transforming properties of a polyomavirus in vitro. Immortalization of primary rat cells is essentially carried out by the HaPV large T (LT) antigen and coexpression of HaPV MT and HaPV small T (ST) antigen is required for full transformation of rat fibroblasts. The preferential binding of HaPV MT to c-Fyn, a Src family kinase, has been proposed as a mechanism leading to lymphoid malignancies.
Heterologous expression of HaPV-VP1 allowed the formation of virus like particles (VLPs) resembling HaPV particles. The high flexibility of HaPV-VP1 for insertion of foreign peptides offers a broad range of potential applications, especially in vaccine development.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Graffi A., Schramm T., Bender E., Bierwolf D., and Graffi I., Arch Geschwulstforsch 30, 227-283, 1967.
GraffI A., Schramm T., Graffi I., Bierwolf D., and Bender E., J Natl Cancer Inst 40, 867-873, 1968.
Graffi A., Bender E., Schramm T., Graffi I., and Bierwolf D., Comp Leukemia Res Bibl Haematol 36, 293-303, 1970.
Graffi I., Bierwolf D., Schramm T., Bender E., and Graffi A., Arch Geschwulstforsch 40, 191-236, 1972.
Heinecke H., Monatsberichte der Deutschen Akademie der Wissenschaften zu Berlin, 7, 52-56, 1965.
Coggin J.M., Jr., Hyde B.M., Heath L.S., Leinbach S.S., Fowler E., and Stadtmore L.S., J Natl Cancer Inst 75, 91-97, 1985.
Böttger M. and Scherneck S., Arch Geschwulstforsch 55, 225-233, 1985.
Böttger M., Bierwolf D., Wunderlich V., and Graffi A., Biochim Biophys Acta 232, 21-31, 1971.
Hassen S., Özel M., Jandrig B., Voronkova T., Jia W., Zocher R., Arnold W., Scherneck S., Krüger D.H., and Ulrich R., Virus Genes 18, 39-47, 1998.
Delmas V., Bastien C., Scherneck S., and Feunteun J., EMBO J 4, 1279-1286, 1985.
De la Roche Saint Andre C., Delmas V., Bastien C., Goutebrouze L., Scherneck S., and Feunteun J., in Villareal L.P., and Washington D.C. (eds.) Common-Mechanism of Transformation by Small DNA Tumor Viruses, American Society for Microbiology, Washington, pp. 225-238, 1989.
Zur Hausen H. and Gissmann L., Med Microbiol Immunol 167, 137-153, 1979.
Vogel F., Rhode K., Scherneck S., Bastien C., Delmas V., and Feunteun S., Virology 154, 335-343.
Ulrich R., Sommerfeld K., Schröder A., Prokoph H., Arnold W., Krüger D.H., and Scherneck S., Virus Genes 12, 265-274, 1996.
Sasnauskas K., Buzaite O., Vogel F., Jandrig B., Razanskas R., Staniulis J., Scherneck S., Krüger D.H., and Ulrich R., Biol Chem 380, 381-386, 1999.
Scherneck S., and Feunteun J., in Barbanti-Brodano G., Bendinelli M., and Friedmann H. (eds.) DNA Tumor Viruses-Oncogenic Mechanisms, Plenum Press, New York, pp. 1-14, 1996.
Giri I. and Danos O., Trends Genet 2, 227-232, 1986.
Dawe C.J., Freund R., Mandel G., Balmer-Hofer K, Talmage D., and Benjamin T.L., Am J Pathol 127, 243-261, 1987.
Bender E., Schramm T., Graffi A., and Schneider F., Arch Geschwulstforsch 34, 144-151, 1969.
Graffi A., Bender E., Schramm T., Kuhn W., and Schneider F., Proc Natl Acad Sci USA 64, 1172-1175, 1969.
De la Roche Saint Andre C., Mazur S., and Feunteun J., J Virol 67, 7172-7180, 1993.
Mazur S., Feunteun J., and De la Roche Saint André C., J Virol 69, 3059-3066, 1995.
Mazur S., Goodhardt M., Feunteun J., and De la Roche Saint André C., J Virol 68, 5629-5637, 1994.
Prokoph H., Jandrig B., Arnold W., and Scherneck S., Arch Virol 142, 53-63, 1997.
Prokoph H., Arnold W., Schwartz A., and Scherneck S., J Gen Virol 77, 2165-2172, 1996.
Barthold S.W., Bhatt P.N., and Johnson E.A., Anim Sci 37, 283-287, 1987.
Hoffman S., Arnold W., Becker K., Rüdiger K.-D., and Scherneck S., Biol Zentralbl. 108, 13-18, 1989.
De la Roche Saint Andre C., Harper F., and Feunteun J., Virology 177, 532-540, 1990.
Diamandopoulos G.T., Science 176, 173-175, 1972.
De la Roche Saint Andre C. and Feunteun J., J Gen Virol 74, 125-128, 1993.
Bastien C. and Feunteun J., Oncogene 2, 129-135, 1988.
Pipas J.M., J Virol 66, 3979-3985, 1992.
Rassoulzadegan M., Cowie A., Carr A., Glaichenhaus N. Kamen R., and Cuzin F., Nature 300, 713-718, 1982.
Goutebrouze L. and Feunteun J., J Virol 66, 2495-2504, 1992.
Cherington V., Morgan B., Spiegelman B.M., and Roberts T.M., Proc Natl Acad Sci U.S.A. 83, 4307-4311, 1986.
Dyson N., Bernards R., Friend S.H., Gooding L.R., Hassell J.A., Major E.O., Pipas J.M., Vandyke T., and Harlow E., J Virol 64, 1353-1356, 1990.
Goutebrouze L., De la Roche Saint Andre C., Scherneck S., and Feunteun S., Oncogene 8, 685-693, 1993.
Kiefer F., Courtneidge S.A., and Wagner E.F., Adv Cancer Res 64, 125-158, 1994.
Goutebrouze L., Dunant N.M., Ballmer-Hofer K., and Feunteun J., J Virol 71, 1436-1442, 1997.
Dilworth S.M., Trends Microbiol 3, 31-35, 1995.
Dunant N. and Ballmer-Hofer K., Cell Signal 9, 385-393, 1997.
Brizuela L., Ulug E.T., Jones M.A., and Courtneidge S.A., Eur J Immunol 25, 385-393, 1995.
Courtneidge S.A., Goutebrouze L., Cartwright A., Heber A., Scherneck S., and Feunteun J., J Virol 65, 3301-3308, 1991.
Krüger D.H., Ulrich R., and Gerlich W.H., Biol Chem 380, 275-276, 1999.
Gedvilaite A., Frömmel C., Sausnauskas K., Micheel B., Özel M., Behrsing O., Staniulis J., Jandrig B., Scherneck S., and Ulrich R., Virology 273, 21-35, 2000.
Forstova J., Krauzewicz N., Sandig V., Elliott J., Palkova Z., Strauss M., and Griffin B.E., Hum Gene Ther 6, 297-306, 1995.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scherneck, S., Ulrich, R. & Feunteun, J. The Hamster Polyomavirus—a Brief Review of Recent Knowledge*. Virus Genes 22, 93–101 (2001). https://doi.org/10.1023/A:1008190504521
Issue Date:
DOI: https://doi.org/10.1023/A:1008190504521